IL37 and inflammatory bowel disease: However, when BSB was administered 3 days before IBD, it significantly (p < 0.05, p > 0.001, n = 6) reduced the IL-23 colonic tissue levels from 127.59 ± 5.46 (no BSB) to 67.71 ± 6.56 pg/mg of protein (BSB, n = 6) on day 4 and from 94.54 ± 10.63 to 54.34 ± 13.27 (n = 6) pg/mg of protein on day 7.